The patient was treated as NSCLC according to the NCCN guidelines for CUP [3]: localized adenocarcinoma, mediastinal clinical presentation, TTF-1 positivity, and age of ≥50 years. This evidence concerns the gene TTF1 and adenocarcinoma.